<DOC>
	<DOCNO>NCT00027521</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Electroporation therapy may enhance ability chemotherapy drug enter tumor cell . Combining chemotherapy electroporation therapy may kill tumor cell . PURPOSE : Phase I trial study effectiveness electroporation therapy bleomycin treat patient locally advanced pancreatic cancer .</brief_summary>
	<brief_title>Electroporation Therapy With Bleomycin Treating Patients With Pancreatic Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine safety surgical feasibility electroporation therapy bleomycin patient locally advanced pancreatic cancer . II . Determine overall progression-free survival patient treat regimen . OUTLINE : Patients receive bleomycin intratumorally laparotomy . Approximately 15 minute intratumoral injection , patient receive bleomycin IV 10 minute . Approximately 5 minute IV injection , patient undergo electroporation therapy comprise electrical pulse directly pancreas surround tissue . Patients follow weekly 4-6 week every 2 month thereafter . PROJECTED ACCRUAL : A total 15 patient accrue study within 12-18 month .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Bleomycin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis adenocarcinoma pancreas Unresectable disease exploratory laparotomy Involvement superior mesenteric artery occlusion superior mesenteric veinportal vein confluence No extrapancreatic metastasis ultrasound , CT scan , laparotomy Tumor must accessible direct injection study drug placement electrode array PATIENT CHARACTERISTICS : Age : Any age Performance status : Karnofsky 70100 % Life expectancy : Not specify Hematopoietic : Not specify Hepatic : AST ALT great 3 time upper limit normal No impair hepatic function Renal : Creatinine great 1.5 mg/dL No impair renal function Cardiovascular : No impaired cardiac function Pulmonary : No compromised pulmonary function No pulmonary condition would potentially require use high FIO2 level Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception 6 month study No prior reaction bleomycin No fever , infection , medical condition would preclude study Not high risk complication associate abdominal surgery PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior lifetime cumulative dose bleomycin great 400 U Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>stage III pancreatic cancer</keyword>
	<keyword>adenocarcinoma pancreas</keyword>
</DOC>